A detailed history of Velan Capital Investment Management LP transactions in Liquidia Corp stock. As of the latest transaction made, Velan Capital Investment Management LP holds 300,000 shares of LQDA stock, worth $4.83 Million. This represents 7.29% of its overall portfolio holdings.

Number of Shares
300,000
Previous 300,000 -0.0%
Holding current value
$4.83 Million
Previous $3 Million 17.6%
% of portfolio
7.29%
Previous 6.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $2.67 Million - $4.23 Million
300,000 New
300,000 $3 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.04B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.